IGM Biosciences Inc (NAS:IGMS)
$ 12.3 0.91 (7.99%) Market Cap: 729.62 Mil Enterprise Value: 459.23 Mil PE Ratio: 0 PB Ratio: 5.52 GF Score: 34/100

Q4 2022 IGM Biosciences Inc Earnings Call Transcript

Mar 30, 2023 / 08:30PM GMT
Release Date Price: $17.02 (-1.45%)
Operator

Good day, everyone, and welcome to IGM Biosciences Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Call. Today's call is being recorded.

At this time, I would like to turn the call over to Fred Schwarzer, Chief Executive Officer of IGM.

Fred M. Schwarzer
IGM Biosciences, Inc. - CEO, President & Director

Thank you, operator, and thanks to all of you joining us on this call. On behalf of IGM, I'm joined today by Misbah Tahir, Chief Financial Officer; Dr. Chris Takimoto, Chief Medical Officer; Dr. Bruce Keyt, Chief Scientific Officer; and Dr. Mary Beth Harler, President, IGM Autoimmunity and Inflammation.

Please note that we will be making forward-looking statements on this call including statements about IGM's plans, expectations and forecasts and about future events. Actual results may differ materially as a result of various risks and uncertainties including those discussed in the company's most recent annual report on Form 10-K as well as its other filings with the SEC.

Any forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot